The Three-year Shareholder Returns and Company Earnings Persist Lower as Guangzhou Kingmed Diagnostics Group (SHSE:603882) Stock Falls a Further 9.0% in Past Week
As an investor, mistakes are inevitable. But really big losses can really drag down an overall portfolio. So take a moment to sympathize with the long term shareholders of Guangzhou Kingmed Diagnost
Jinyu Medical (603882): Affected by the external environment and credit impairment, short-term pressure waits for an upward inflection point in profits
Core view: Jinyu Medical announced the 2023 and 2024Q1 results. In '23, the company achieved revenue of 8.540 billion yuan (-44.82%); net profit to mother of 643 million yuan (-76.64%); after deducting non-payment
Dean Diagnosis (300244): Impairment calculation affects apparent performance First quarter results are lower than expected
Event: The company released its report for the first quarter of 2024. In the first quarter of 2024, it achieved operating income of 2,973 billion yuan (-8.01%), net profit to mother of 0.23 million yuan (-85.54%), deducting non-net profit
American Health (002044): The trend of increasing customer unit prices in 2023 is evident, and performance is growing strongly
Announcement: American Health released its 2023 annual report, 2024 quarterly report, strong growth in 2023 performance, and a significant increase in profitability. 2023 operating income of 10.89 billion yuan (+26.4%), net profit to mother
Shenzhen Gongjin Electronics Co., Ltd. (SHSE:603118) Surges 6.3%; Individual Investors Who Own 48% Shares Profited Along With Insiders
Key Insights Significant control over Shenzhen Gongjin Electronics by individual investors implies that the general public has more power to influence management and governance-related decisions A t
Investors Still Aren't Entirely Convinced By Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) Earnings Despite 25% Price Jump
Despite an already strong run, Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329) shares have been powering on, with a gain of 25% in the last thirty days. Unfortunately, th